MX2020003670A - Metodos para tratar infecciones bacterianas. - Google Patents
Metodos para tratar infecciones bacterianas.Info
- Publication number
- MX2020003670A MX2020003670A MX2020003670A MX2020003670A MX2020003670A MX 2020003670 A MX2020003670 A MX 2020003670A MX 2020003670 A MX2020003670 A MX 2020003670A MX 2020003670 A MX2020003670 A MX 2020003670A MX 2020003670 A MX2020003670 A MX 2020003670A
- Authority
- MX
- Mexico
- Prior art keywords
- subject
- methods
- subjects
- treating bacterial
- transplant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Métodos para tratar la infección bacteriana en sujetos inmunodeprimidos y sujetos con una o mas neoplasias subyacentes que incluyen la administración al sujeto de una combinación de meropenem y vaborbactam. Los sujetos adecuados a tratar pueden incluir un sujeto con un antecedente de leucemia o linfoma en curso, un sujeto que ha tenido un trasplante de órgano, trasplante de células madre, trasplante de medula ósea, o esplenectomia, un sujeto que recibe medicamentos inmunosupresores, un sujeto que recibe quimioterapia ablativa de medula ósea, un sujeto con neutropenia y un sujeto que padece o que ha padecido de una neoplasia.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762567702P | 2017-10-03 | 2017-10-03 | |
US201862657402P | 2018-04-13 | 2018-04-13 | |
PCT/US2018/053772 WO2019070591A1 (en) | 2017-10-03 | 2018-10-01 | METHODS OF TREATING BACTERIAL INFECTIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020003670A true MX2020003670A (es) | 2020-08-03 |
Family
ID=65994826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020003670A MX2020003670A (es) | 2017-10-03 | 2018-10-01 | Metodos para tratar infecciones bacterianas. |
Country Status (15)
Country | Link |
---|---|
US (2) | US11376237B2 (es) |
EP (1) | EP3691652A4 (es) |
JP (1) | JP2020536092A (es) |
KR (1) | KR20200066664A (es) |
CN (1) | CN111432821A (es) |
AU (1) | AU2018345317A1 (es) |
BR (1) | BR112020006658A2 (es) |
CA (1) | CA3078238A1 (es) |
CL (1) | CL2020000892A1 (es) |
JO (1) | JOP20200075A1 (es) |
MX (1) | MX2020003670A (es) |
PH (1) | PH12020550249A1 (es) |
SG (1) | SG11202003009QA (es) |
TW (2) | TW202400146A (es) |
WO (1) | WO2019070591A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111432821A (zh) | 2017-10-03 | 2020-07-17 | 梅琳塔治疗公司 | 治疗细菌感染的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10561675B2 (en) * | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
CN112755039A (zh) * | 2015-04-24 | 2021-05-07 | 莱姆派克斯制药公司 | 治疗细菌感染的方法 |
MX2019008281A (es) * | 2017-01-09 | 2019-12-02 | Rempex Pharmaceuticals Inc | Metodos para tratar infecciones bacterianas. |
CN111432821A (zh) | 2017-10-03 | 2020-07-17 | 梅琳塔治疗公司 | 治疗细菌感染的方法 |
-
2018
- 2018-10-01 CN CN201880072552.XA patent/CN111432821A/zh active Pending
- 2018-10-01 WO PCT/US2018/053772 patent/WO2019070591A1/en unknown
- 2018-10-01 JO JOP/2020/0075A patent/JOP20200075A1/ar unknown
- 2018-10-01 JP JP2020519066A patent/JP2020536092A/ja active Pending
- 2018-10-01 CA CA3078238A patent/CA3078238A1/en active Pending
- 2018-10-01 EP EP18863923.1A patent/EP3691652A4/en active Pending
- 2018-10-01 SG SG11202003009QA patent/SG11202003009QA/en unknown
- 2018-10-01 AU AU2018345317A patent/AU2018345317A1/en active Pending
- 2018-10-01 US US16/753,288 patent/US11376237B2/en active Active
- 2018-10-01 KR KR1020207012784A patent/KR20200066664A/ko not_active Application Discontinuation
- 2018-10-01 BR BR112020006658-3A patent/BR112020006658A2/pt not_active Application Discontinuation
- 2018-10-01 MX MX2020003670A patent/MX2020003670A/es unknown
- 2018-10-02 TW TW112133851A patent/TW202400146A/zh unknown
- 2018-10-02 TW TW107134824A patent/TW201922241A/zh unknown
-
2020
- 2020-04-02 CL CL2020000892A patent/CL2020000892A1/es unknown
- 2020-04-03 PH PH12020550249A patent/PH12020550249A1/en unknown
-
2022
- 2022-05-27 US US17/826,712 patent/US20220288024A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN111432821A (zh) | 2020-07-17 |
TW201922241A (zh) | 2019-06-16 |
US20220288024A1 (en) | 2022-09-15 |
US11376237B2 (en) | 2022-07-05 |
PH12020550249A1 (en) | 2021-02-15 |
EP3691652A4 (en) | 2021-07-07 |
SG11202003009QA (en) | 2020-04-29 |
WO2019070591A1 (en) | 2019-04-11 |
BR112020006658A2 (pt) | 2020-09-24 |
US20200297695A1 (en) | 2020-09-24 |
CL2020000892A1 (es) | 2020-10-23 |
EP3691652A1 (en) | 2020-08-12 |
CA3078238A1 (en) | 2019-04-11 |
JOP20200075A1 (ar) | 2020-04-30 |
AU2018345317A1 (en) | 2020-05-07 |
KR20200066664A (ko) | 2020-06-10 |
JP2020536092A (ja) | 2020-12-10 |
TW202400146A (zh) | 2024-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020551923A1 (en) | Methods and compositions for treating cancer | |
MX2020013169A (es) | Conjugados de camptotecina. | |
MX2019010757A (es) | Métodos y composiciones relacionados con el tratamiento combinado con antiinflamatorios y nanoportadores sintéticos que comprenden un inmunosupresor. | |
NZ742208A (en) | Topical pharmaceutical formulations for treating inflammatory-related conditions | |
MX2022001075A (es) | Compuestos para usarse en el tratamiento de cancer de mama que expresa el receptor de androgenos (ar+). | |
BR112017028413A2 (pt) | peptídeos antimicrobianos estabilizados | |
BR112018072560A2 (pt) | terapia de combinação para tratamento do câncer | |
CL2022001752A1 (es) | Compuesto de piridazinil-tiazolcarboxamida | |
MX2019007613A (es) | Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos. | |
EA202191632A1 (ru) | Ахромосомные динамические активные системы | |
ES2525137B1 (es) | Agentes para tratar el mieloma múltiple | |
BR112017006113A2 (pt) | combinações sinérgicas de auristatina | |
MX2021005603A (es) | Aparato y métodos para dispositivos de vaporización con varios atomizadores, de varias cámaras. | |
MX2017009450A (es) | Composicion yodofora novedosa y metodos de uso. | |
WO2018009528A8 (en) | Combination cancer immunotherapies with arginine depletion agents | |
CO2018008449A2 (es) | Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano | |
CL2018001913A1 (es) | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano | |
CO2020006907A2 (es) | Péptidos antimicrobianos y métodos para usarlos | |
MX2020000249A (es) | Composiciones antimicrobianas efectivas contra bacterias y hongos. | |
MX2021005956A (es) | Composiciones biologicas secas y metodos de las mismas. | |
CL2018001911A1 (es) | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano | |
CL2017002803A1 (es) | Compuestos heterocíclicos y su uso en la prevención o tratamiento de las infecciones bacterianas | |
CL2021001044A1 (es) | Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrización de heridas y la recuperación posoperatoria | |
MX2020003670A (es) | Metodos para tratar infecciones bacterianas. | |
CA3011003A1 (en) | Bacterial ghosts for the treatment of cancer |